In December 2019, the FDA announced approval of Tandem Diabetes Care Control-IQ™ Technology. Control-IQ Technology on the t:slim X2™ insulin pump can adjust basal insulin delivery and deliver automated correction boluses using Dexcom G6 continuous glucose monitoring (CGM) values. It is currently approved for patient ages 14 years and older.
Tandem Diabetes Care Control-IQ Technology Full PDF
1 file(s) 189 KB
[neon_sign_in_link_return class="button fl-button"]Log in to download[/neon_sign_in_link_return]
Posted in New Meds and Tech